Attendees
Sponsors and
Exhibitors
Agenda
Webinars
Contact us
Blog
Nearly half of the attendees (44.7%) rated the organization of the GIANT Health event as "Superb"
This is a positive indicator and implies that a significant portion of the attendees had a highly favorable opinion of how the event was organized.
Read moreEmbracing Veganuary: A heart-healthy initiative to reduce your team’s cholesterol levels
As we step into a new year, there’s a growing trend that’s not only transforming the way we eat but also promoting a healthier, more sustainable lifestyle – Veganuary. Today, we’d like to explore how encouraging your employees to participate…
Read more
Acorn Compliance is bringing you the world's first #AI #compliance platform for #DTAC
Want to know more about the most advance technology in the #healthtech industry? Hosted by Michael Bell, Partner at Acorn Compliance and DTAC expert. RSVP For the #liveLaunch here.
Read moreHorizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third…
Read moreWorkplace Options Announces New Chief Operating Officer
Workplace Options (WPO), a leading provider of in-the-moment wellbeing support, committed to improving the lives of more than 79 million people around the world, selected Eric Santa as its new Chief Operating Officer. The new position will advance the company’s…
Read moreFDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system. Read more here.
Read moreEuropean Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection. Read more here.
Read moreWalking for wellness / Art & soul groups
Check out this fascinating share on walking for wellness / Art & soul groups. Download and read the full project report.
Read moreVirtual Medical Expert Training in Peripheral Bronchoscopy
The Virtual Medical Expert Training gives a comprehensive overview on diagnosis and treatment options for peripheral pulmonary nodules. The aim is to discuss pre-recorded cases and tips & tricks for a safe and effective procedure. Read more here.
Read moreSEHTA registers with Innovate UK’s business growth service’s Catapults & RTOs Grant Scheme
Innovate UK EDGE, the innovation agency’s business growth service, is partnering with Catapults and RTOs across the UK to award 100% funded grants of up to £15,000 to suitable high-growth SMEs as part of their advisory support. Read more here.
Read more
Are you interested in building skills and knowledge in Digital Health Innovation and Entrepreneurship?
Check out The Digital Health Academy launched by Professor Shafi Ahmed
Read moreORCHA & Alpha MD join forces to transform digital health in India
ORCHA, the Organisation for the Review of Health and Care Apps, and Alpha MD, a leading player in healthcare innovation, are proud to announce a strategic partnership aimed at shaping and supporting digital health delivery in India. The collaboration will kick off…
Read more